Task: Answer the multiple-choice question.
Question: Which drug exhibits a 15.699% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a CC(=O)N(CCCCN1C(=O)c2ccccc2C1=O)c1ccc(C)cc1
b COc1cc(/C=C(\C#N)c2ccccn2)ccc1OCc1ccc(Cl)cc1
c Cc1nc(-c2ccccn2)nc(SCC(=O)c2ccccc2)c1Cl
d CCn1cc(SCC(=O)NCC2CCCO2)c2ccccc21
Answer: d. CCn1cc(SCC(=O)NCC2CCCO2)c2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1cc(SCC(=O)NCC2CCCO2)c2ccccc21
CCn1cc(SCC(=O)NCC2CCCO2)c2ccccc21
2-(1-ethylindol-3-yl)sulfanyl-N-(oxolan-2-ylmethyl)acetamide